PROCEPT BioRobotics (PRCT) Stock Analysis & AI Equity Report
PROCEPT BioRobotics (PRCT) overview
PROCEPT BioRobotics (PRCT) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 308m and operating profit of USD -104m; the year-end share price was 31.46 USD and market capitalisation was USD 1,772m. PROCEPT BioRobotics is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get PROCEPT BioRobotics's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
About PROCEPT BioRobotics
PROCEPT BioRobotics develops, manufactures, and sells robotic systems for minimally invasive urologic surgery, initially focused on benign prostatic hyperplasia. Its AquaBeam and HYDROS systems use image-guided robotic technology and disposable handpieces to deliver Aquablation therapy, combining imaging, treatment planning, and heat-free waterjet ablation to remove prostate tissue. The company’s products are used by physicians treating men with urinary symptoms associated with BPH.
Generate the PROCEPT BioRobotics report
PROCEPT BioRobotics is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for PROCEPT BioRobotics and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on PROCEPT BioRobotics
Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.